A Study of the Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid Tumors
Eli Lilly and Company
Eli Lilly and Company
Artios Pharma Ltd
SN BioScience
City of Hope Medical Center
Toray Industries, Inc
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Cancer Research and Biostatistics Clinical Trials Consortium
OHSU Knight Cancer Institute
Daiichi Sankyo